NCT05186753Phase 2Active not recruiting

(Summit) A Study to Evaluate the Efficacy and Safety of CGT9486 Versus Placebo in Patients With Indolent or Smoldering Systemic Mastocytosis

Study sponsor: Cogent Biosciences, Inc. · COGT

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2025-05-22Actual
Enrollment · participants237Estimated
Source updated2026-10-22Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview